Zachary Taylor

Assistant Professor

Cincinnati Children's Hospital Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Zachary Taylor is an Assistant Professor at Cincinnati Children's Hospital Medical Center in the United States. His research focuses on therapeutic drug monitoring, pharmacokinetics, and precision dosing in pediatric patient populations, particularly concerning methotrexate and other psychotropic medications. His recent publications include studies on methotrexate clearance in pediatric malignancies and the impact of pharmacogenetics on drug metabolism in older adults.

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (10)

Daniel Mueller

Full Professor

University of Toronto

CANADA

View details

Lisa Martin

Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

View details

Charles F Reynolds III

Distinguished Professor of Psychiatry, UPMC Endowed Professor in Geriatric Psychitry

University of Pittsburgh School of Medicine

UNITED STATES

View details

Lauren Pommert

Assistant Professor

University of Cincinnati

UNITED STATES

View details

Laura B. Ramsey

UNITED STATES

View details

Holly Lindsay

Associate Professor

University of Colorado Health

UNITED STATES

View details

Daniel Gonzalez

Duke University

UNITED STATES

View details

Michael J Rosen

Stanford University School of Medicine

UNITED STATES

View details

Katherine Somers

Assistant Professor of Clinical Pediatrics

Cincinnati Children's Hospital Medical Center

UNITED STATES

View details

James Kennedy

University of Toronto

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Zachary Taylor

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

What Is the Expected Clearance of Methotrexate? A Therapeutic Drug Monitoring Reference Guide for High‐Dose Methotrexate Use in Pediatric Malignancies

Toxicity profile of high‐dose methotrexate in young children with central nervous system tumors

CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression

Assessment of Dosing Strategies for Pediatric Drug Products

Early therapeutic drug monitoring of methotrexate and its association with acute kidney injury: A retrospective cohort study

Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.org

Effects of obesity on the pharmacology of proton pump inhibitors: current understanding and future implications for patient care and research

Tutorial on model selection and validation of model input into precision dosing software for model‐informed precision dosing

Escitalopram and Sertraline Population Pharmacokinetic Analysis in Pediatric Patients

SLCO1B1 *15 allele is associated with methotrexate‐induced nausea in pediatric patients with inflammatory bowel disease

Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing.

Collaborators (10)

Daniel Mueller

Lisa Martin

Charles F Reynolds III

Lauren Pommert

Laura B. Ramsey

Holly Lindsay

Daniel Gonzalez

Michael J Rosen

Katherine Somers

James Kennedy

Make your next move.